PGY-2 Oncology

The PGY2 oncology pharmacy residency at UPMC Presbyterian Shadyside Hospital is designed for the individual interested in developing specialized clinical expertise in pharmaceutical care for oncology patients. UPMC Presbyterian Shadyside Hospital is a nationally ranked Top 20 cancer hospital which partners with UPMC Hillman Cancer Center that is the only NCI-designated comprehensive cancer center in western Pennsylvania and is one of the most renowned cancer centers in the United States. The oncology pharmacy resident will gain expertise in the management of a wide variety of patients, including oncology, hematology, and hematopoietic stem cell transplant patients, in all phases of their care, both inpatient and outpatient settings. The resident will gain expertise in the pathophysiology of various hematologic and oncologic malignancies and management of these malignancies from both a pharmacologic as well as non-pharmacologic perspective. Additionally, the resident will gain experience in the treatment of oncologic emergencies, adverse reaction monitoring and management of chemotherapy, biotherapy, immunotherapy, therapeutic drug monitoring, and management of drug interactions.

The resident will be integrally involved in research opportunities and education of students and other healthcare professionals. Through the Resident Research Series, the resident will identify a practice-related research project and mentor, learn about study design and implementation as well as complete a residency project suitable for publication. An optional Teaching Mastery Series allows residents to learn about various teaching methods as well as develop their skills as pharmacy educators and clinical preceptors. Many opportunities to present formal seminars, patient cases, journal clubs, and in-service education for UPMC staff occur throughout the year. The resident will gain experience in both didactic and experiential teaching and precepting at the University of Pittsburgh School of Pharmacy. Flexibility is provided to meet the individual resident's goals and objectives.

Program objectives include:

  1. Demonstrate proficiency, confidence, and compassion in providing direct patient care to a wide variety of oncology/hematology/stem cell transplant patients

  2. Demonstrate professionalism and effective communication skills in all components of pharmacy practice

  3. Optimize pharmacotherapy and safe medication practices

  4. Provide effective education to healthcare professionals

  5. Apply clinical and outcomes research concepts to professional practice

Highly motivated individuals with a strong interest in oncology who are committed to providing optimal pharmaceutical care within a team-oriented setting are encouraged to apply.

All residents must be eligible for pharmacist licensure in the Commonwealth of Pennsylvania. Applications for Pharmacist License and Intern Registration are available.

Application Process

Eligible candidates will have completed an ASHP accredited PGY1 pharmacy residency program and must submit the standard application requirements via PhORCAS by December 31st. An on-site interview is required.

This residency site agrees that no person at this site will solicit, accept, or use any ranking related information from any residency candidate.

To prepare pharmacists to assume any of the following roles:

  • Oncology clinical specialist

  • Pharmacy educator

Our residents will become confident, effective practitioners of pharmacotherapy. Residents will focus on ensuring application of safe, effective and evidence-based medicine practices to patients with a variety of oncologic and hematologic malignancies in the health system. These practitioners will demonstrate competency in educating their patients as well as present and future health care professionals.

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

Duration: 12 months
Number Positions: 1
Starting Date: July 1
Salary: $51,037
Benefits: Health, dental, eye care, life, and disability available, vacation and professional travel provided, travel stipend available
Training Site Type: Hospital
Owner/Affiliates: Private
Model (type): Teaching, tertiary
Professional Staff: 100+
Total Beds: 520+





Inpatient Medical Oncology - Team A

4 weeks

Inpatient Medical Oncology - Team B

4 weeks

Leukemia I  - Inpatient Hematology

4 weeks

Leukemia II - Inpatient Hematology

4 weeks

Team H - Inpatient Hematology

4 weeks

Inpatient BMT I (Autologous HSCT/CAR-T)

4 weeks

Inpatient BMT II (Allogeneic HSCT)

4 weeks

Investigational Drug Service (IDS)

4 weeks

Outpatient Ambulatory Care Oncology

4 weeks

Oncology Pre-Admissions (OPA)

4 weeks

Professional Development

4 weeks




Inpatient Infectious Diseases (ID)

4 weeks

Pediatric BMT

4 weeks

Pediatric Oncology

4 weeks

Gynecologic Oncology

4 weeks

Elective of any required learning experience

4 weeks





12 months

Outpatient Clinic

12 months

Staffing (every 3rd weekend)

12 months


Other elective rotations are available based on resident interest and faculty availability.


Timothy L. Brenner, PharmD, BCOP (Residency Program Director)

Amanda Agnew, PharmD, BCOP (Residency Program Coordinator)

James J. Natale, PharmD, BCOP

Shrina Duggal, PharmD, BCOP

Jason Steele, PharmD, BCOP

Timothy George, PharmD, BCOP

Brian Miller, PharmD

Karen Fancher, PharmD, BCOP

Breana Goscicki, PharmD, BCPPS

Louis-Marie Oleksiuk, PharmD, BCPS

Michael Trisler, PharmD, MPH

Jeffrey Goff, RPh, MS


UPMC Presbyterian - Shadyside (Shadyside Campus, inpatient rotations)

UPMC Hillman Cancer Center - Shadyside (outpatient rotations)

UPMC Cancer Center at Passavant – McCandless (outpatient rotation)

UPMC Children’s Hospital of Pittsburgh (pediatric BMT rotation)

To view the PGY-2 Oncology Pharmacy Residency Manual, click here.

Program Director

Timothy L. Brenner, PharmD, BCOP
Clinical Pharmacy Specialist
PGY-2 Oncology Residency Program Director
UPMC Presbyterian Shadyside Hospital / UPMC Cancer Center
UPMC Cancer Pavilion, Room 456
5150 Centre Ave
Pittsburgh, PA 15232
Phone: 412-297-1209

UPMC Presbyterian